Follow the ValiRx PLC stock price and the full insider trade history of the company, a publicly traded company based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). Market capitalisation: €2.1m. The latest transaction was filed on 4 March 2026 (Purchase). Among the most active insiders: Mark Eccleston. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
ValiRx PLC 是一家生物制药公司,专注于开发癌症及其他疾病的治疗方法。该公司在伦敦证券交易所上市。